Digitally Delivered Dietary Treament for Adult Patients With Irritable Bowel Syndrome: A Pilot Study
Key facts
- Who runs it
- Sahlgrenska University Hospital
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 32 people enrolled
- Started
- 2 May 2024
- Ended
- 1 Apr 2025
- Type of study
- Interventional
- Treatments tested
- Digital dietary platform
- Record updated
- 28 May 2026
Who can take part
- Age
- 18 years to 64 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Diagnosed with IBS (Rome IV) by physician
- Age 18-64
- Ability to read and understand Swedish
- Signed informed consent
Who cannot take part
- Received dietary treatmen for IBS previously
- Manifestations of other conditions that may explain gastrointestinal symptoms
- Manifestation of other serious medical conditions
- Patients with ongoing eating disorders
- Pregnant/lactating women
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Two carbohydrate reduced diets, the low FODMAP diet (LFD) and low-carbohydrate diet (LCD), have in randomized controlled studies shown efficacy in relieving symptoms in patients with Irritable Bowel Syndrome (IBS), but access to trained dieticians is limited. Digital delivery may offer a convenient, cost-effective and scalable solution. This pilot study aims to evaluate the effectiveness and feasibility of digitally delivered evidence-based dietary treatments in relieving gastrointestinal, psychological and somatic symptoms and improving quality of life in patients with IBS.
Read full original descriptionShow less
Adults with IBS will be recruited via social media and clinical referrals and will receive their choice of the two dietary treatments: LFD with traditional IBS dietary advice or LCD. Participants will get access to the digital platform which contains information about the study, IBS pathophysiology, the treatment diet along with recipes and a mobile application for food scanning. Participants will complete digital questionnaires at baseline and week four to evaluate changes in gastrointestinal symptoms (IBS-SSS), somatic and psychological symptoms (PHQ-15, HADS, VSI) and quality of life (IBS-QoL). Feasibility and adherence is assessed with an evaluation questionnaire.
The group in the trial
- Digital delivery of low FODMAP diet or low-carbohydrate dietOther group
Treatment: Digital dietary platform
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Digitally Delivered Dietary Treament for Irritable Bowel Syndrome
- Record updated
- 28 May 2026